U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06959186) titled 'Risk Stratification Via HF-QRS and Fibrosis Biomarkers in Heart Failure' on April 28.
Brief Summary: This study aims to evaluate whether high-frequency QRS (HF-QRS) signal parameters and circulating myocardial fibrosis biomarkers (such as PIIINP, Galectin-3, and sST2) can improve risk stratification in patients with chronic heart failure (CHF). In this prospective, multicenter cohort study (STRIVE cohort), patients with CHF will be enrolled and followed for 18 months. Clinical data, routine heart function measures (such as NT-proBNP and LVEF), HF-QRS features from standard 12-lead ECG, and serum fibrosis biomarker levels will be colle...